Full Text View
Tabular View
No Study Results Posted
Related Studies
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), December 2008
First Received: January 27, 2009   Last Updated: February 6, 2009   History of Changes
Sponsors and Collaborators: Mayo Clinic
National Cancer Institute (NCI)
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00830557
  Purpose

RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future.

PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.


Condition Intervention
Islet Cell Tumor
Pancreatic Cancer
Other: medical chart review
Other: survey administration
Procedure: study of high risk factors

MedlinePlus related topics: Cancer Pancreatic Cancer Pancreatic Diseases
U.S. FDA Resources
Study Type: Observational
Official Title: Biospecimen Resource for Pancreas Research, a Data & Tissue Bank (Also Known as a Bio-Repository, Bio-Bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • Collection of clinical data, health and family histories by survey [ Designated as safety issue: No ]
  • Collection of blood and/or tissue, fecal and oral specimens [ Designated as safety issue: No ]
  • Collection of information regarding food preparation and intake by survey [ Designated as safety issue: No ]
  • Establish a medical information and biospecimen bank for future research studies [ Designated as safety issue: No ]

Estimated Enrollment: 5000
Study Start Date: October 2000
Detailed Description:

OBJECTIVES:

Primary

  • To collect clinical data and family histories and blood and/or tissue samples from patients diagnosed with pancreatic diseases, including pancreatic cancer, for use in future studies.
  • To collect information regarding food preparation and intake in these patients.

Secondary

  • To make available to researchers medical data and biospecimens to enable them to develop better ways to screen people at risk for pancreatic conditions, including pancreatic cancer.
  • To investigate genes or substances that increase susceptibility of developing pancreatic conditions.
  • To find agents that may help prevent, treat, or cure these conditions.
  • To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic cancer, or other cancers.

OUTLINE: This is a multicenter study.

Patients complete two 1-hour surveys assessing health, clinical and family history of pancreatic conditions including cancer, and food preparation and intake. Patients also complete a 15- to 30-minute follow up survey at 6 months and 1 year to assess health, health practices, and family history. A review of the patient's medical information is obtained from the medical record.

Blood samples are collected for future research studies. Oral cells and stool samples may also be collected for future studies.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

DISEASE CHARACTERISTICS:

  • Diagnosis or suspicion of at least one of the following:

    • Pancreatic cancer
    • Pancreatic mass
    • Islet cell tumor
    • Intraductal papillary mucinous neoplasms (IPMN)
    • Hereditary pancreatitis

PATIENT CHARACTERISTICS:

  • Able to understand and read English
  • Mentally competent and able to provide informed consent
  • Has not donated blood within the past 8 weeks

PRIOR CONCURRENT THERAPY:

  • At least 7 days since prior blood transfusion
  • At least 7 days since prior surgery
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00830557

Locations
United States, Minnesota
Mayo Clinic Cancer Center Recruiting
Rochester, Minnesota, United States, 55905
Contact: Clinical Trials Office - All Mayo Clinic Locations     507-538-7623        
Sponsors and Collaborators
Mayo Clinic
Investigators
Principal Investigator: Gloria M. Petersen, PhD Mayo Clinic
  More Information

Additional Information:
No publications provided

Study ID Numbers: CDR0000613100, MAYO-35406
Study First Received: January 27, 2009
Last Updated: February 6, 2009
ClinicalTrials.gov Identifier: NCT00830557     History of Changes
Health Authority: Unspecified

Keywords provided by National Cancer Institute (NCI):
recurrent pancreatic cancer
stage I pancreatic cancer
stage II pancreatic cancer
stage III pancreatic cancer
stage IV pancreatic cancer
recurrent islet cell carcinoma
pancreatic alpha cell carcinoma
pancreatic beta islet cell carcinoma
pancreatic delta cell carcinoma
pancreatic G-cell carcinoma

Study placed in the following topic categories:
Pancreatic Islet Cell Tumors
Digestive System Neoplasms
Pancreatic Neoplasms
Carcinoma, Islet Cell
Endocrine System Diseases
Adenoma, Islet Cell
Pancrelipase
Recurrence
Carcinoma
Digestive System Diseases
Pancreatic Diseases
Gastrointestinal Neoplasms
Endocrinopathy
Adenoma
Endocrine Gland Neoplasms
Neoplasms, Glandular and Epithelial

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Histologic Type
Digestive System Diseases
Neoplasms by Site
Digestive System Neoplasms
Pancreatic Neoplasms
Endocrine System Diseases
Pancreatic Diseases
Adenoma, Islet Cell
Adenoma
Neoplasms, Glandular and Epithelial
Endocrine Gland Neoplasms

ClinicalTrials.gov processed this record on May 06, 2009